6xHis-SENP8
Product Sizes
100 ug
£633.00
H9821-100UG
About this Product
- SKU:
- H9821
- Buffer:
- Powder; no buffer
- Extra Details:
- PF-07321332 is an orally active covalent inhibitor of the 3C-like protease by direct binding of the catalytic cysteine 145. 3CL protease cleaves polyproteins 1a and 1ab of SARS-CoV-2, a step required for reproduce the virus. The PF-07321332/ritonavir combination drug (trade name Paxlovid) is efficient for the treatment of COVID-19 as, in November 2021, Pfizer announced phase 2/3 clinal trial results that the drug treatment reduced 89% in hospitalizations when given within three days after symptom onset. This product is for research use only.
- Molecular Weight:
- 499.53 g/mol
- Shipping Conditions:
- Dry Ice
- Source:
- chemical synthesis
- Storage Conditions:
- -20 0C
- Supplier:
- UBP Bio
- Type:
- Proteins, Peptides, Small Molecules & Other Biomolecules
